No black box warning on record for Rasagiline

As of the latest FDA labeling reviewed, Rasagiline (RASAGILINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rasagiline medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses (5.1) May cause serotonin syndrome when used with antidepressants (5.2) May cause falling asleep during activities of daily living, daytime drowsiness, and somnolence (5.3) May cause hypotension, especially orthostatic (5.6) May cause or exacerbate dyskinesia. Decreasing the levodopa do

No black box warning on record for Rasagiline

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses (5.1) May cause serotonin syndrome when used with antidepressants (5.2) May cause falling asleep during activities of daily living, daytime drowsiness, and somnolence (5.3) May cause hypotension, especially orthostatic (5.6) May cause or exacerbate dyskinesia. Decreasing the levodopa do

Rasagiline Black Box Warning

No black box warning on record for Rasagiline

Other warnings & precautions

Rasagiline Black Box Warning

No black box warning on record for Rasagiline

Other warnings & precautions